清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The Impact of PSMA PET–Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy

医学 前列腺癌 谷氨酸羧肽酶Ⅱ 放射性配体 内科学 肿瘤科 抗原 前列腺 癌症 泌尿科 受体 免疫学
作者
Amir Karimzadeh,Matthias Heck,Robert Tauber,Esteban Solaris,Stephan G. Nekolla,Karina Knorr,Bernhard Haller,Calogero D’Alessandria,Wolfgang Weber,Matthias Eiber,Isabel Rauscher
出处
期刊:The Journal of Nuclear Medicine [Society of Nuclear Medicine and Molecular Imaging]
卷期号:64 (8): 1252-1258 被引量:11
标识
DOI:10.2967/jnumed.122.265346
摘要

Prostate-specific membrane antigen (PSMA) radioligand therapy (RLT) has shown encouraging results for treatment of metastatic castration-resistant prostate cancer (mCRPC) in the prospective, multicenter, randomized phase II TheraP study. The inclusion criteria for that study comprised a pretherapeutic 68Ga-PSMA-11 PET scan showing sufficient tumor uptake using a predefined threshold and the absence of 18F-FDG–positive, PSMA ligand–negative tumor lesions. However, the prognostic value of these PET-based inclusion criteria remains unclear. Therefore, we evaluated the outcome of mCRPC patients treated with PSMA RLT using TheraP as well as other TheraP-based PET inclusion criteria. Methods: First, patients were dichotomized into 2 groups whose PSMA PET scans did (TheraP contrast-enhanced PSMA [cePSMA] PET–positive) or did not (TheraP cePSMA PET–negative) fulfill the inclusion criteria of TheraP. Notably, unlike in TheraP, 18F-FDG PET was not performed on our patients. Prostate-specific antigen (PSA) response (PSA decline ≥ 50% from baseline), PSA progression-free survival, and overall survival (OS) were compared. Additionally, patients were further dichotomized according to predefined SUVmax thresholds different from those used in TheraP to analyze their potential impact on outcome as well. Results: In total, 107 mCRPC patients were included in this analysis (TheraP cePSMA PET–positive, n = 77; TheraP cePSMA PET–negative, n = 30). PSA response rates were higher in TheraP cePSMA PET–positive patients than in TheraP cePSMA PET–negative patients (54.5% vs. 20%, respectively; P = 0.0012). The median PSA progression-free survival (P = 0.007) and OS (P = 0.0007) of patients were significantly longer in the TheraP cePSMA PET–positive group than in the TheraP cePSMA PET–negative group. Moreover, being in the TheraP cePSMA PET–positive group was identified as a significant prognosticator of longer OS (P = 0.003). The application of different SUVmax thresholds for a single hottest lesion demonstrated no influence on outcome in patients eligible for PSMA RLT. Conclusion: Patient selection for PSMA RLT according to the inclusion criteria of TheraP led to a better treatment response and outcome in our preselected patient cohort. However, a relevant number of patients not fulfilling these criteria also showed substantial rates of response.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
woxinyouyou完成签到,获得积分10
9秒前
10秒前
13秒前
暴躁莹子发布了新的文献求助10
16秒前
AthurMarcus发布了新的文献求助30
19秒前
21秒前
含糊的青烟完成签到 ,获得积分10
24秒前
搞怪代荷发布了新的文献求助30
33秒前
SciGPT的应助被Fighter采纳,获得10
36秒前
悦耳乘风完成签到,获得积分10
37秒前
41秒前
Fighter发布了新的文献求助10
47秒前
48秒前
酷酷的海莲完成签到,获得积分10
1分钟前
Aman完成签到,获得积分10
1分钟前
Aman完成签到,获得积分10
1分钟前
无极微光的应助被暴躁莹子采纳,获得20
1分钟前
暴躁莹子完成签到,获得积分10
1分钟前
kuaidi123完成签到 ,获得积分10
1分钟前
神勇友安完成签到,获得积分10
1分钟前
无私的碧玉完成签到,获得积分10
1分钟前
Maestro_S的应助被levosimendan采纳,获得10
1分钟前
烟花的应助被Fighter采纳,获得10
2分钟前
2分钟前
LINDENG2004完成签到 ,获得积分10
2分钟前
Fighter发布了新的文献求助10
2分钟前
芋圆完成签到 ,获得积分20
2分钟前
随心所欲完成签到 ,获得积分0
2分钟前
2分钟前
2分钟前
yc发布了新的文献求助10
2分钟前
2分钟前
成就云朵完成签到,获得积分10
2分钟前
Yolo完成签到 ,获得积分10
3分钟前
重要寄瑶完成签到,获得积分10
3分钟前
上官若男的应助被Fighter采纳,获得10
3分钟前
3分钟前
Fighter发布了新的文献求助10
4分钟前
科研通AI6.3的应助被amiee采纳,获得10
4分钟前
精明开山完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190190
求助须知:如何正确求助?哪些是违规求助? 9577298
关于积分的说明 21852333
捐赠科研通 7788645
什么是DOI,文献DOI怎么找? 3436310
关于科研通互助平台的介绍 2560076
邀请新用户注册赠送积分活动 2482902